Pharmaceutical Technology on MSN

BD invests $110m to expand US prefillable syringe production

BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the ...
Fierce Pharma

BD budgets $110M to expand Neb. syringe production

The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...
Pharmaceutical Technology

SCHOTT Doubles Production Capacity for Polymer Syringes

SCHOTT has been expanding its manufacturing capacity for small size (1ml to 10 ml) SCHOTT TopPac® syringes in order ...
Drug Delivery Business

BD to invest $110M to support prefilled syringe production, pharma supply chain

BD (NYSE:BDX) announced today that it invested $110 million to expand its production of prefillable syringes in Columbus, ...
Pharmaceutical Technology

SCHOTT Reveals Growth Goals for its Global Syringe Business

SCHOTT has announced that it plans to achieve further growth in its prefillable syringe line. Dr Jürgen Sackhoff, executive ...

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million ...
Contract Pharma

BD to Invest $110M to Expand Production of Prefillable Syringes

BD is investing $110 million to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug delivery.
MD&M East

BD Increases US Syringe Production After FDA Warnings on China-Made Syringes

Becton, Dickinson and Company (BD) has announced its intention to increase US production of syringes after FDA recently reported that its ongoing investigation into quality issues with plastic ...